Supplementary Figure S22 from Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure S22 displays the coexpression of DLL3, SEZ6 and B7H3 for patient 36.
Authors: Avanish Mishra, Catherine B. Meador, Kruthika Kikkeri, Quinn Cunneely, Maoxuan Lin, Thomas J. Carmona-LaSalle, Shih-Bo Huang, Remy Bell, Victor Putaturo, Weikun Xia, Joyce H. Liang, Jacy Fang, Sarah San Vicente, Caroline E. Zielinski, Subba R. Digumarthy, Yin P. Hung, Beow Y. Yeap, Jon F. Edd, Michael S. Lawrence, Moshe Sade-Feldman, Debattama R. Sen, Mehmet Toner, Shyamala Maheswaran, Justin F. Gainor, Daniel A. Haber
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165142912
Cites:
Cited by:
Related to: